FDA approves tafasitamab with lenalidomide and rituximab, offering a groundbreaking chemotherapy-free treatment for relapsed ...

The findings highlight the importance of having an EP versed in lead management on the heart valve team, one expert says.

New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg SP ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...

The increasing prevalence of overweight and obesity in China poses an urgent public health challenge requiring immediate ...

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

The University of Kansas Medical Center has been awarded a five-year, $31 million grant from the National Institutes of ...

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is ...

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is ...